Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer

S Soumyajit Roy Y Yilun Sun (Department of Pharmacology, Physiology, and Drug Development, University of Maryland School of Medicine) M Maha Hussain K Kim N. Chi K Karim Fizazi (Centre Oscar Lambret, University of Paris-Saclay, Lille, France) I Ian D. Davis (School of Medicine, Monash University) S Susan Halabi (From the Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda (A.B.A., N.S., S.N., L.L., L.C.), the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.H.-C.), and the Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville (H.S., E.S.) — all in Maryland; the Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN (K.V.B., M.O., C.M., G.P.B.); AdventHealth Cancer Institute and the University of Central Florida, Orlando (G.S.); Dana–Farber/Harvard Cancer Center, Boston (S.B., B.M.); UNC Lineberger Comprehensive Cancer Center, Chapel Hill (W.Y.K.), and Duke University Medical Center and Duke Cancer Institute, Durham (J.H., S.H.) — both in North Carolina; the University of Kansas Cancer Center, Westwood (R.P.); Memorial Sloan Kettering Cancer Center, New York (M.Y.T., M.J.M., J.E.R.), and Roswell Park Comprehensive Cancer Center, Buffalo (G.C.) — both in...) N Neeraj Agarwal (Division of Medical Oncology Department of Internal Medicine Huntsman Cancer Institute University of Utah Salt Lake City Utah USA) S Simon Chowdhury B Bertrand Tombal S Scott C. Morgan S Shawn Malone P Pedro C. Barata (Division of Solid Tumor Oncology, Department of Medicine University Hospitals, Cleveland Medical Center Case Western Reserve University School of Medicine Cleveland Ohio USA) M Michael Ong C Christopher J. D. Wallis A Alejandro Berlin U Umang Swami (Division of Medical Oncology Department of Internal Medicine Huntsman Cancer Institute University of Utah Salt Lake City Utah USA) A Amar U. Kishan A Angela Y. Jia N Nicholas G. Zaorsky J Jorge A. Garcia P Prateek Mendiratta J Jason R. Brown V Vinod V. Subhash M Martin R. Stockler H Hayley Thomas R Rana R. McKay (Department of Medicine, Urology, and Radiation Medicine and Applied Sciences University of California‐San Diego La Jolla California USA) E Eric J. Small N Neal D. Shore (START Carolinas/Carolina Urologic Research Center, Myrtle Beach, SC) F Fred Saad (Centre Hospitalier de l’Université de Montréal, University of Montreal, Montreal) C Christopher J. Sweeney D Daniel E. Spratt

Article Details

Volume / Issue Vol. 17, Issue 1
Published December 17, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (32)

S

Soumyajit Roy

Y

Yilun Sun

Department of Pharmacology, Physiology, and Drug Development, University of Maryland School of Medicine

M

Maha Hussain

K

Kim N. Chi

K

Karim Fizazi

Centre Oscar Lambret, University of Paris-Saclay, Lille, France

I

Ian D. Davis

School of Medicine, Monash University

S

Susan Halabi

From the Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda (A.B.A., N.S., S.N., L.L., L.C.), the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.H.-C.), and the Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville (H.S., E.S.) — all in Maryland; the Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN (K.V.B., M.O., C.M., G.P.B.); AdventHealth Cancer Institute and the University of Central Florida, Orlando (G.S.); Dana–Farber/Harvard Cancer Center, Boston (S.B., B.M.); UNC Lineberger Comprehensive Cancer Center, Chapel Hill (W.Y.K.), and Duke University Medical Center and Duke Cancer Institute, Durham (J.H., S.H.) — both in North Carolina; the University of Kansas Cancer Center, Westwood (R.P.); Memorial Sloan Kettering Cancer Center, New York (M.Y.T., M.J.M., J.E.R.), and Roswell Park Comprehensive Cancer Center, Buffalo (G.C.) — both in...

N

Neeraj Agarwal

Division of Medical Oncology Department of Internal Medicine Huntsman Cancer Institute University of Utah Salt Lake City Utah USA

S

Simon Chowdhury

B

Bertrand Tombal

S

Scott C. Morgan

S

Shawn Malone

P

Pedro C. Barata

Division of Solid Tumor Oncology, Department of Medicine University Hospitals, Cleveland Medical Center Case Western Reserve University School of Medicine Cleveland Ohio USA

M

Michael Ong

C

Christopher J. D. Wallis

A

Alejandro Berlin

U

Umang Swami

Division of Medical Oncology Department of Internal Medicine Huntsman Cancer Institute University of Utah Salt Lake City Utah USA

A

Amar U. Kishan

A

Angela Y. Jia

N

Nicholas G. Zaorsky

J

Jorge A. Garcia

P

Prateek Mendiratta

J

Jason R. Brown

V

Vinod V. Subhash

M

Martin R. Stockler

H

Hayley Thomas

R

Rana R. McKay

Department of Medicine, Urology, and Radiation Medicine and Applied Sciences University of California‐San Diego La Jolla California USA

E

Eric J. Small

N

Neal D. Shore

START Carolinas/Carolina Urologic Research Center, Myrtle Beach, SC

F

Fred Saad

Centre Hospitalier de l’Université de Montréal, University of Montreal, Montreal

C

Christopher J. Sweeney

D

Daniel E. Spratt